| Locally renewing resident synovial macrophages provide a protective barrier for the joint S Culemann, A Grüneboom, JÁ Nicolás-Ávila, D Weidner, KF Lämmle, ... Nature 572 (7771), 670-675, 2019 | 436 | 2019 |
| Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies A Kleyer, S Finzel, J Rech, B Manger, M Krieter, F Faustini, E Araujo, ... Annals of the rheumatic diseases 73 (5), 854-860, 2014 | 392 | 2014 |
| Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus A Mackensen, F Müller, D Mougiakakos, S Böltz, A Wilhelm, M Aigner, ... Nature medicine 28 (10), 2124-2132, 2022 | 388 | 2022 |
| Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease R Pfeifle, T Rothe, N Ipseiz, HU Scherer, S Culemann, U Harre, ... Nature immunology 18 (1), 104-113, 2017 | 344 | 2017 |
| Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis N Tajik, M Frech, O Schulz, F Schälter, S Lucas, V Azizov, K Dürholz, ... Nature communications 11 (1), 1995, 2020 | 335 | 2020 |
| Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled … J Haschka, M Englbrecht, AJ Hueber, B Manger, A Kleyer, M Reiser, ... Annals of the rheumatic diseases 75 (1), 45-51, 2016 | 248 | 2016 |
| IgA subclasses have different effector functions associated with distinct glycosylation profiles U Steffen, CA Koeleman, MV Sokolova, H Bang, A Kleyer, J Rech, ... Nature communications 11 (1), 120, 2020 | 210 | 2020 |
| SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases D Simon, K Tascilar, F Fagni, G Krönke, A Kleyer, C Meder, R Atreya, ... Annals of the rheumatic diseases 80 (10), 1312-1316, 2021 | 197 | 2021 |
| Signature of circulating microRNAs in osteoarthritis C Beyer, A Zampetaki, NY Lin, A Kleyer, C Perricone, A Iagnocco, ... Annals of the rheumatic diseases 74 (3), e18-e18, 2015 | 189 | 2015 |
| German mobile apps in rheumatology: review and analysis using the Mobile Application Rating Scale (MARS) J Knitza, K Tascilar, EM Messner, M Meyer, D Vossen, A Pulla, P Bosch, ... JMIR mHealth and uHealth 7 (8), e14991, 2019 | 150 | 2019 |
| Th2 and eosinophil responses suppress inflammatory arthritis Z Chen, D Andreev, K Oeser, B Krljanac, A Hueber, A Kleyer, ... Nature communications 7 (1), 11596, 2016 | 145 | 2016 |
| The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts J Friščić, M Böttcher, C Reinwald, H Bruns, B Wirth, SJ Popp, KI Walker, ... Immunity 54 (5), 1002-1021. e10, 2021 | 144 | 2021 |
| Mobile health usage, preferences, barriers, and eHealth literacy in rheumatology: patient survey study J Knitza, D Simon, A Lambrecht, C Raab, K Tascilar, M Hagen, A Kleyer, ... JMIR mHealth and uHealth 8 (8), e19661, 2020 | 133 | 2020 |
| Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging C Schmidkonz, S Rauber, A Atzinger, R Agarwal, TI Götz, A Soare, ... Annals of the rheumatic diseases 79 (11), 1485-1491, 2020 | 131 | 2020 |
| Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study EG Araujo, M Englbrecht, S Hoepken, S Finzel, E Kampylafka, A Kleyer, ... Seminars in arthritis and rheumatism 48 (4), 632-637, 2019 | 126 | 2019 |
| PPARβ/δ governs Wnt signaling and bone turnover C Scholtysek, J Katzenbeisser, H Fu, S Uderhardt, N Ipseiz, C Stoll, ... Nature medicine 19 (5), 608-613, 2013 | 123 | 2013 |
| Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis F Faustini, D Simon, I Oliveira, A Kleyer, J Haschka, M Englbrecht, ... Annals of the rheumatic diseases 75 (12), 2068-2074, 2016 | 118 | 2016 |
| Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion D Simon, K Tascilar, G Krönke, A Kleyer, MM Zaiss, F Heppt, C Meder, ... Nature communications 11 (1), 3774, 2020 | 104 | 2020 |
| Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment J Rech, AJ Hueber, S Finzel, M Englbrecht, J Haschka, B Manger, ... Annals of the rheumatic diseases 75 (9), 1637-1644, 2016 | 104 | 2016 |
| JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function S Adam, N Simon, U Steffen, FT Andes, C Scholtysek, DIH Müller, ... Science translational medicine 12 (530), eaay4447, 2020 | 100 | 2020 |
